Elutia (ELUT) Stock: Buy, Sell, or Hold?

ELUT - Elutia Inc. Class A Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$0.84
-0.02 (-2.79%) â–ŧ
5d: +5.48%
30d: +0.9%
90d: -12.8%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 05, 2026 11d

Get Alerted When ELUT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: ELUT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ELUT is currently trading at $0.84, which is considered slightly high relative to its 30-day fair value range of $0.78 to $0.84.

Technical Outlook: Technically, ELUT is in a strong downtrend. Immediate support is located at $0.71, while resistance sits at $0.88.

Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.00 (+497.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $0.78 - $0.84
Company Quality Score 44/100 (HOLD)
Volume Confirmation MODERATE
Confidence Score 61.6%

All Signals

  • NEUTRAL: Mixed technical signals (51/100)
  • BULLISH: Trading 497.0% below Wall St target ($5.00)
  • WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $0.78 - $0.84
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $0.71
Resistance Level $0.88
Current Trend Strong Downtrend
Technical data as of Oct 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.55
Wall Street Target $5.00 (+497.0%)
Revenue Growth (YoY) -11.6%
Profit Margin 426.9%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 24, 2026 3:05 AM ET
Data refreshes hourly during market hours. Next update: 4:05 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ELUT.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
EW
Edwards Lifesciences Corp
STRONG BUY
29 analysts
$102 58 HOLD
DXCM
DexCom Inc
STRONG BUY
29 analysts
$96 46 HOLD
ABT
Abbott Laboratories
STRONG BUY
28 analysts
$121 52 HOLD
BSX
Boston Scientific Corp
STRONG BUY
31 analysts
$59 41 HOLD
SYK
Stryker Corporation
STRONG BUY
29 analysts
$363 37 SELL

More Analysis for ELUT

ELUT Technical Chart ELUT Price Prediction ELUT Earnings Date ELUT Investment Advisor ELUT Fair Price Analyzer ELUT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals